Perspective Therapeutics CATX
NYSE CATX
$2.31 +0.01 (+0.55%)
As of: Oct 21, 2026 · 1:42 PM EDT

Perspective Therapeutics (CATX) Tax Provisions (2023)

Updated

Perspective Therapeutics' Tax Provisions came in at $7.85 million for Q4 2023.

Analysis

Perspective Therapeutics (CATX) Tax Provisions (2023) Analysis & Trends

For FY2023, Perspective Therapeutics' Tax Provisions was -$2.65 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,133.99 Bn 1,102.58 Bn 19.71 Bn 2.15 Bn
2 Johnson & Johnson 615.70 Bn 534.23 Bn 17.26 Bn 1.21 Bn
3 AbbVie 501.05 Bn 474.16 Bn 12.70 Bn 662.00 Mn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 654.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.01 Bn
6 Astrazeneca 261.20 Bn 234.88 Bn 12.86 Bn 291.00 Mn
7 Amgen 235.55 Bn 190.95 Bn 7.24 Bn 393.00 Mn
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn 242.00 Mn
9 Pfizer 169.29 Bn 115.93 Bn 10.94 Bn -407.00 Mn
10 Perspective Therapeutics 279.31 Mn 42.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 7.85 Mn
Mar 31, 2023 -10.50 Mn
API Access

Perspective Therapeutics Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=CATX&period=max&api_key=YOUR_API_KEY